Qualyst Transporter Solutions offers innovative solutions by discovering, developing, and providing products that predict in vivo behavior.

Qualyst Transporter Solutions, LLC is a new joint venture which has acquired the B‐CLEAR® technology, originally developed and commercialized by Qualyst, Inc., in order to maximize the number and type of related applications across the pharmaceutical and toxicological markets. B‐CLEAR® technology, now licensed exclusively to Qualyst Transporter Solutions, is the leading in vitro model that provides in vivo relevant data in the pharmaceutical industry. B‐CLEAR® determines the hepatic disposition ...

Qualyst Transporter Solutions, LLC is a new joint venture which has acquired the B‐CLEAR® technology, originally developed and commercialized by Qualyst, Inc., in order to maximize the number and type of related applications across the pharmaceutical and toxicological markets. B‐CLEAR® technology, now licensed exclusively to Qualyst Transporter Solutions, is the leading in vitro model that provides in vivo relevant data in the pharmaceutical industry. B‐CLEAR® determines the hepatic disposition of drugs, evaluates transporter‐based drug interactions, and predicts hepatic toxicity.